Skip to content

Sanara MedTech Inc. SMTI Net additions (releases) charged to costs and expenses

Net additions (releases) charged to costs and expenses at other companies

Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s net additions (releases) charged to costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s net additions (releases) charged to costs and expenses?
Sanara MedTech Inc. (SMTI) reported net additions (releases) charged to costs and expenses of $75K in Q1 2026.
How has Sanara MedTech Inc.'s net additions (releases) charged to costs and expenses changed year-over-year?
Sanara MedTech Inc.'s net additions (releases) charged to costs and expenses decreased by 58.1% year-over-year, from $179.03K to $75K.
What is the long-term trend for Sanara MedTech Inc.'s net additions (releases) charged to costs and expenses?
Over 4 years (2021 to 2025), Sanara MedTech Inc.'s net additions (releases) charged to costs and expenses has grown at a 77.3% compound annual growth rate (CAGR), from $51.54K to $509.23K.